Express Pharma

Tata Trusts and Gilead collaborates to address hepatitis burden

2

Will form a Joint Program Committee to implement prevention, awareness and education, testing and treatment, and health systems strengthening activities

Tata Trusts and Gilead Sciences have signed a Memorandum of Understanding (MoU) under the presence of Ratan Tata, Chairman, Tata Trusts to explore collaborating within India on an initiative to address the burden of viral hepatitis in the country. This effort takes place in the context of an expanding focus on the public health challenges posed by serious diseases, including viral hepatitis, representing significant unmet medical needs in India.

Under the MoU, Tata Trusts and Gilead will form a Joint Program Committee to implement activities pertaining to prevention, awareness and education, testing and treatment, and health systems strengthening activities in the field of viral hepatitis in India. Linkages with state governments, non-governmental organisations and public health agencies will be established to promote the cause.

Comments are closed.